These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 411726)
1. Characterization of glycosaminoglycans stored in mucopolysaccharidosis III A: evidence for a generally occuring degradation of heparan sulfate by endoglycosidases. Kindler A; Klein U; von Figura K Hoppe Seylers Z Physiol Chem; 1977 Nov; 358(11):1431-8. PubMed ID: 411726 [TBL] [Abstract][Full Text] [Related]
2. A new biochemical subtype of the Sanfilippo syndrome: characterization of the storage material in cultured fibroblasts of Sanfilippo C patients. Kresse H; Von Figura K; Klein U Eur J Biochem; 1978 Dec; 92(2):333-9. PubMed ID: 153835 [TBL] [Abstract][Full Text] [Related]
3. Evidence for degradation of heparan sulfate by endoglycosidases: glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts. Klein U; Kresse H; von Figura K Biochem Biophys Res Commun; 1976 Mar; 69(1):158-66. PubMed ID: 130905 [No Abstract] [Full Text] [Related]
4. Defective heparan sulfate metabolism in the Sanfilippo syndrome and assay of this defect in the assessment of the mucopolysaccharidoses patient. Gordon BA; Feleki V; Budreau CH; Tyler L Clin Biochem; 1975 Jun; 8(3):184-93. PubMed ID: 238759 [TBL] [Abstract][Full Text] [Related]
5. Sanfilippo disease type D: deficiency of N-acetylglucosamine-6-sulfate sulfatase required for heparan sulfate degradation. Kresse H; Paschke E; von Figura K; Gilberg W; Fuchs W Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6822-6. PubMed ID: 6450420 [TBL] [Abstract][Full Text] [Related]
6. Characterization of dermatan sulfate in mucopolysaccharidosis VI. Evidence for the absence of hyaluronidase-like enzymes in human skin fibroblasts. Klein U; von Figura K Biochim Biophys Acta; 1980 Jun; 630(1):10-4. PubMed ID: 6770909 [TBL] [Abstract][Full Text] [Related]
7. Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans in normals and four types of mucopolysaccharidoses. Constantopoulos G; McComb RD; Dekaban AS J Neurochem; 1976 May; 26(5):901-8. PubMed ID: 131847 [No Abstract] [Full Text] [Related]
8. Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans, lipids and lysosomal enzymes in mucopolysaccharidosis type III B (alpha-N-acetylglucosaminidase deficiency). Constantopoulos G; Eiben RM; Schafer IA J Neurochem; 1978 Nov; 31(5):1215-22. PubMed ID: 100580 [No Abstract] [Full Text] [Related]
9. Demonstration of D-glucuronic acid as reducing terminal of intracellular heparan sulfates. Klein U; von Figura K FEBS Lett; 1976 Dec; 71(2):266-8. PubMed ID: 137126 [No Abstract] [Full Text] [Related]
10. Glycosaminoglycan levels and structure in a mucopolysaccharidosis IIIA mice and the effect of a highly secreted sulfamidase engineered to cross the blood-brain barrier. Maccari F; Sorrentino NC; Mantovani V; Galeotti F; Fraldi A; Volpi N Metab Brain Dis; 2017 Feb; 32(1):203-210. PubMed ID: 27585464 [TBL] [Abstract][Full Text] [Related]
11. Chemical definition of the mucopolysaccharidoses. Constantopoulos G; Dekaban AS Clin Chim Acta; 1975 Mar; 59(3):321-36. PubMed ID: 123832 [TBL] [Abstract][Full Text] [Related]
12. Secondary storage of dermatan sulfate in Sanfilippo disease. Lamanna WC; Lawrence R; Sarrazin S; Esko JD J Biol Chem; 2011 Mar; 286(9):6955-62. PubMed ID: 21193389 [TBL] [Abstract][Full Text] [Related]
13. Heparan sulfate and dermatan sulfate from the liver of a patient with Hurler syndrome: high performance liquid chromatography of their degradation products after incubation with alpha-L-iduronidase-deficient fibroblasts. Minami R; Fujibayashi S; Igarashi C; Ishikawa Y; Wagatsuma K; Nakao T; Tsugawa S Clin Chim Acta; 1984 Feb; 137(2):179-87. PubMed ID: 6231139 [TBL] [Abstract][Full Text] [Related]
14. Mobilization of heparan sulfate induced by immunostimulation in a patient with mucopolysaccharidosis IIIA. Zerial M; Florio C; Dolzani L; Moro L; Romeo D Biochem Med; 1984 Apr; 31(2):228-35. PubMed ID: 6232924 [TBL] [Abstract][Full Text] [Related]
15. Metastatic melanoma cell heparanase. Characterization of heparan sulfate degradation fragments produced by B16 melanoma endoglucuronidase. Nakajima M; Irimura T; Di Ferrante N; Nicolson GL J Biol Chem; 1984 Feb; 259(4):2283-90. PubMed ID: 6698965 [TBL] [Abstract][Full Text] [Related]
16. Glycosaminoglycans and mucopolysaccharidosis type III. Jakobkiewicz-Banecka J; Gabig-Ciminska M; Kloska A; Malinowska M; Piotrowska E; Banecka-Majkutewicz Z; Banecki B; Wegrzyn A; Wegrzyn G Front Biosci (Landmark Ed); 2016 Jun; 21(7):1393-409. PubMed ID: 27100513 [TBL] [Abstract][Full Text] [Related]
17. Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains. Ginsberg SD; Galvin JE; Lee VM; Rorke LB; Dickson DW; Wolfe JH; Jones MZ; Trojanowski JQ J Neuropathol Exp Neurol; 1999 Aug; 58(8):815-24. PubMed ID: 10446806 [TBL] [Abstract][Full Text] [Related]
18. Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III. de Ruijter J; de Ru MH; Wagemans T; Ijlst L; Lund AM; Orchard PJ; Schaefer GB; Wijburg FA; van Vlies N Mol Genet Metab; 2012 Dec; 107(4):705-10. PubMed ID: 23084433 [TBL] [Abstract][Full Text] [Related]
19. Lysosomal storage of heparan sulfate causes mitochondrial defects, altered autophagy, and neuronal death in the mouse model of mucopolysaccharidosis III type C. Pshezhetsky AV Autophagy; 2016 Jun; 12(6):1059-60. PubMed ID: 25998837 [TBL] [Abstract][Full Text] [Related]
20. Mucopolysaccharidosis III A (Sanfilippo disease type A). Histochemical, electron microscopical and biochemical findings. Cain H; Egner E; Kresse H Beitr Pathol; 1977 Apr; 160(1):58-72. PubMed ID: 405006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]